The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.

IF 1.9 4区医学 Q4 IMMUNOLOGY AIDS reviews Pub Date : 2021-02-08 DOI:10.24875/AIDSRev.200001261

Daniel O Griffin, Denise Brennan-Rieder, Binh Ngo, Pierre Kory, Marco Confalonieri, Leland Shapiro, Jose Iglesias, Michael Dube, Neha Nanda, Gino K In, Daniel Arkfeld, Preet Chaudhary, Vito M Campese, Diana L Hanna, David Sawcer, Glenn Ehresmann, David Peng, Miroslaw Smorgorzewski, April Amstrong, Eivind H Vinjevoll, Rajkumar Dasgupta, Fred R Sattler, Cristina Mussini, Oriol Mitjà, Vicente Soriano, Nicolas Peschanski, Gilles Hayem, Maria Carmela Piccirillo, António Lobo-Ferreira, Iraldo B Rivero, Ivan F H Hung, Marc Rendell, Stephen Ditmore, Joseph Varon, Paul Marik

{"title":"The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.","authors":"Daniel O Griffin, Denise Brennan-Rieder, Binh Ngo, Pierre Kory, Marco Confalonieri, Leland Shapiro, Jose Iglesias, Michael Dube, Neha Nanda, Gino K In, Daniel Arkfeld, Preet Chaudhary, Vito M Campese, Diana L Hanna, David Sawcer, Glenn Ehresmann, David Peng, Miroslaw Smorgorzewski, April Amstrong, Eivind H Vinjevoll, Rajkumar Dasgupta, Fred R Sattler, Cristina Mussini, Oriol Mitjà, Vicente Soriano, Nicolas Peschanski, Gilles Hayem, Maria Carmela Piccirillo, António Lobo-Ferreira, Iraldo B Rivero, Ivan F H Hung, Marc Rendell, Stephen Ditmore, Joseph Varon, Paul Marik","doi":"10.24875/AIDSRev.200001261","DOIUrl":null,"url":null,"abstract":"<p><p>COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment of COVID-19 and advancing therapeutics is an appreciation of the multiple stages of this disease and the importance of timing for investigation and use of various agents. We considered articles related to COVID-19 indexed on PubMed published January 1, 2020-November 15, 2020, and considered papers on the medRxiv preprint server. We identified relevant stages of COVID-19 including three periods: pre-exposure, incubation, and detectable viral replication; and five phases: the viral symptom phase, the early inflammatory phase, the secondary infection phase, the multisystem inflammatory phase, and the tail phase. This common terminology should serve as a framework to guide when COVID-19 therapeutics being studied or currently in use is likely to provide benefit rather than harm.</p>","PeriodicalId":7685,"journal":{"name":"AIDS reviews","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2021-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"62","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/AIDSRev.200001261","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 62

Abstract

COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment of COVID-19 and advancing therapeutics is an appreciation of the multiple stages of this disease and the importance of timing for investigation and use of various agents. We considered articles related to COVID-19 indexed on PubMed published January 1, 2020-November 15, 2020, and considered papers on the medRxiv preprint server. We identified relevant stages of COVID-19 including three periods: pre-exposure, incubation, and detectable viral replication; and five phases: the viral symptom phase, the early inflammatory phase, the secondary infection phase, the multisystem inflammatory phase, and the tail phase. This common terminology should serve as a framework to guide when COVID-19 therapeutics being studied or currently in use is likely to provide benefit rather than harm.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

了解COVID-19治疗和试验阶段的重要性。

由SARS-CoV-2引起的COVID-19自2019年12月在中国武汉首次发现以来，一直是一个重大的健康问题。迄今为止，已经尝试了多种药物来治疗COVID-19。对COVID-19治疗和推进治疗方法至关重要的是认识到这种疾病的多个阶段以及调查和使用各种药物的时机的重要性。我们考虑了2020年1月1日至2020年11月15日在PubMed上发表的与COVID-19相关的文章，以及在medRxiv预印本服务器上发表的论文。我们确定了COVID-19的相关阶段，包括三个时期:暴露前、潜伏期和可检测的病毒复制;五个阶段:病毒症状期、早期炎症期、继发感染期、多系统炎症期、尾期。这一通用术语应作为一个框架，指导正在研究或目前使用的COVID-19治疗方法何时可能带来益处而不是危害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

AIDS reviews 医学-传染病学

CiteScore

3.40

自引率

4.50%

发文量

审稿时长

>12 weeks

期刊介绍： AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research which contribute to the overall knowledge of the field of the acquired immunodeficiency syndrome and human retrovirology. Currently, the Journal publishes review articles (usually by invitation, but spontaneous submitted articles will also be considered). Manuscripts submitted to AIDS Reviews will be accepted on the understanding that the authors have not submitted the paper to another journal or published the material elsewhere.

期刊最新文献

Strengthen the doctor-patient relationship and avoid administrative stifling. International HTLV Conference, London, June 3-5, 2024. On the origin of life on earth. HTLV-1/2 infection in Italy: a narrative review of epidemiological studies. Early and contemporary drivers of the HIV-1 group M pandemic.